The Consumer Healthcare Products Association (CHPA) released the following statement today from John Troup, Ph.D., CHPA Vice President of Scientific Affairs and Dietary Supplements in response to new research published in Clinical Toxicology on March 23, 2021. The study found nine illegal stimulants, including deterenol, in fraudulently marketed sports and weight loss supplements:
“The Clinical Toxicology study is an example of companies that aren’t established and reputable leaders in the dietary supplement industry selling dangerous, fraudulent products that pose significant public health risk.
“The Dietary Supplement Health and Education Act (DSHEA) of 1994 continues to provide a strong regulatory framework for dietary supplements, including Good Manufacturing Practice (cGMP) requirements for manufacturing, packaging, labeling, and other quality system procedures. Consumers should know that this behavior is a very minor part of the industry, with responsible supplement manufacturers following the law by adhering to these rigorous quality control standards. It’s these reputable manufacturers who provide important health and wellness products that are not adulterated and allow consumer confidence in product safety and quality. CHPA supports increased efforts by the U.S. Food and Drug Administration (FDA) to hold those who violate the law and jeopardize public health accountable.
“CHPA and our members support DSHEA modernization efforts to help continue to protect public health, including ridding the market of illegal products that pose a danger to consumers and tarnish the reputation of established, credible supplement industry leaders.”
“Consumers should always seek out reputable companies and be wary of supplements with claims that are ‘too good to be true’. Learn more from the CHPA Educational Foundation.”